The Gly→Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 5, 2000, Pages 2004-2013

  Hribal, Marta Letizia ^a   Federici, Massimo ^a   Porzio, Ottavia ^a   Lauro, Davide ^b   Borboni, Patrizia ^a   Accili, Domenico ^c   Lauro, Renato ^a   Sesti, Giorgio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; GLUCOSE; GLUCOSE TRANSPORTER; GLYCINE; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; AKT1 PROTEIN, HUMAN; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; MUSCLE PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; SLC2A1 PROTEIN, HUMAN; SLC2A4 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; CELL MEMBRANE; CODON; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; INSULIN METABOLISM; INSULIN RESISTANCE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENETICS; KINETICS; METABOLISM; PHOSPHORYLATION; SKELETAL MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SUBSTITUTION; ANIMALS; ARGININE; CELL LINE; CELL MEMBRANE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; GLYCINE; GLYCOGEN; HUMANS; INSULIN; KINETICS; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PHOSPHORYLATION; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; RECOMBINANT PROTEINS; TRANSFECTION; VARIATION (GENETICS);

EID: 0034351407     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.5.2004     Document Type: Article

References (45)

1. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes
2. Insulin action and the insulin signaling network
3. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
4. Role of IRS-2 in insulin and cytokine signalling
5. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family
6. Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells
7. The Insulin signalling system and the IRS proteins
8. Alternative pathways of insulin signalling in mice with targeted disruption of the IRS-1 gene
9. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
10. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin-receptor substrate-1
11. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines
12. Disruption of IRS-2 causes type 2 diabetes in mice
13. Amino acid polymorphism in insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus Lancet
14. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus
15. Insulin resistance: Interaction between obesity and a common variant of insulin receptor substrate-1
16. Molecular scanning of the IRS-1 gene In Japanese patients with non-insulin-dependent diabetes mellitus: Identification of five novel mutations in IRS-1 gene
17. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes
18. 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations
19. A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease
20. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk for noninsulin-dependent diabetes mellitus
21. Amino acid polymorphism Gly 972 Arg in iRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes
22. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians
23. Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes
24. Search for variants of the gene-promoter and the potential phosphotyrosine encoding sequence of the insulin receptor substrate-2 gene: Evaluation of their relation with alteration in insulin secretion and insulin sensitivity
25. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
26. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells
27. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase. DNA synthesis, and glucose transporters translocation
28. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells
29. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
30. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
31. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
32. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis
33. Constitutive activation of protein kinase B α by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells
34. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells
35. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling
36. Impact of natural IRS-1 mutations on insulin signals
37. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects
38. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes
39. Peptide-based radioimmunoassay for the two isoforms of the human insulin receptor
40. Expression of variant forms of insulin receptor substrate-1 identified in patients with noninsulin-dependent diabetes mellitus
41. 1152 mutant receptor
42. 972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells
43. Insulin signalling and insulin actions in the muscle and livers of insulin-resistant, insulin receptor substrate 1-deficient mice
44. Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes
45. Insulin receptor substrate-2 is not necessary for insulin- and exercise-stimulated glucose transport in skeletal muscle